<DOC>
	<DOCNO>NCT01053494</DOCNO>
	<brief_summary>This clinical trial study massage therapy give caregiver treat quality life young patient undergoing treatment cancer . Massage therapy give caregiver may improve quality life young patient undergoing treatment cancer</brief_summary>
	<brief_title>Massage Therapy Given Caregiver Treating Quality Life Young Patients Undergoing Treatment Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine feasibility acceptability conduct massage intervention childhood cancer patient primary caregiver . II . To investigate feasibility implement brief target massage train protocol caregiver . III . To identify barrier recruitment , intervention adherence , full study completion consent family . IV . To assess preliminary effectiveness massage intervention reduce caregiver child psychological distress ( anxiety , depression , parent stress ) promote child health-related quality life . V. To compare outcome data two intervention arm ( TOUCH : child massage ; TOUCH+ : Caregiver massage plus child massage ) arm wait list control condition . VI . To utilize pilot data development contextually specific target grant application fully power randomize control trial efficacy caregiver massage child undergo treatment cancer . SECONDARY OBJECTIVES : I . To investigate reciprocal change self-reported psychosocial functioning within caregiver-child dyad baseline post-intervention . II . To assess impact massage intervention upon level stress biomarker ( cortisol ) caregiver child assess association cortisol level self-reported psychosocial functioning . OUTLINE : Patients caregiver randomize 1 3 treatment arm . ARM I ( WAITLIST CONTROL GROUP ) : Patients caregiver receive standard care offer massage intervention 8 week . ARM II ( TOUCH ) : Caregivers undergo 60-minute training session simple massage technique , include `` Massage Toolkit , '' comprise Swedish Massage Trigger Point Therapy Massage , week 0 booster 60-minute massage training session week 4 licensed massage therapist . Caregivers instruct massage child least 3 20-minute session per week 8 week . ARM III ( TOUCH+ ) : Caregivers undergo 60-minute training session simple massage technique , include `` Massage Toolkit , '' comprise Swedish Massage Trigger Point Therapy Massage , week 0 booster 60-minute massage training session week 4 licensed massage therapist . Caregivers instruct massage child least 3 20-minute session per week 8 week . Caregivers also receive 45-minute massage massage therapist . Patients complete questionnaire week 0 , 8 , 16 . After completion study treatment , patient caregiver follow 8 week .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Burkitt Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Large-Cell , Immunoblastic</mesh_term>
	<mesh_term>Plasmablastic Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<mesh_term>Sezary Syndrome</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Acute</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Chronic</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Polycythemia</mesh_term>
	<mesh_term>Polycythemia Vera</mesh_term>
	<mesh_term>Leukemia , Hairy Cell</mesh_term>
	<mesh_term>Thrombocytosis</mesh_term>
	<mesh_term>Leukemia , Myeloid , Chronic-Phase</mesh_term>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large-Cell , Anaplastic</mesh_term>
	<mesh_term>Immunoblastic Lymphadenopathy</mesh_term>
	<mesh_term>Leukemia , Prolymphocytic</mesh_term>
	<mesh_term>Lymphoma , Extranodal NK-T-Cell</mesh_term>
	<mesh_term>Leukemia , Myeloid , Chronic , Atypical , BCR-ABL Negative</mesh_term>
	<mesh_term>Hypereosinophilic Syndrome</mesh_term>
	<mesh_term>Thrombocythemia , Essential</mesh_term>
	<mesh_term>Lymphomatoid Granulomatosis</mesh_term>
	<mesh_term>Blast Crisis</mesh_term>
	<mesh_term>Lymphoproliferative Disorders</mesh_term>
	<mesh_term>Leukemia , Myeloid , Accelerated Phase</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Juvenile</mesh_term>
	<mesh_term>Leukemia , Large Granular Lymphocytic</mesh_term>
	<mesh_term>Leukemia , Neutrophilic , Chronic</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<mesh_term>Intraocular Lymphoma</mesh_term>
	<mesh_term>Leukemia , Mast-Cell</mesh_term>
	<criteria>Signed protocol specific inform consent child 's caregiver Assent child Caregiver least 18 year age The child currently treat cancer ( chemotherapy alone , radiation therapy alone , chemotherapy radiation therapy , chemotherapy surgery , radiation therapy surgery ) Wake Forest Baptist Health ( WFBH ) Pediatric Oncology The child least 16 week remain treatment regimen The caregiver child understand write spoken English The child medical functional contraindication report his/her attending\physician Parents/caregivers previously provide consistent massage child exclude study Child receiving radiation</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>